GLP ‐1 Receptor Agonism Exacerbates Activity‐Based Anorexia in Mice
International Journal of Eating Disorders · 2026-11 · 59 (11) · 2549-2554
DOI: 10.1002/eat.70169 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Eating Disorders, online erschienen am 08.07.2026. Verfasst von Amit Thakar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Anorexia, Motor Activity. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists reduce food intake and body weight, suggesting they should be avoided in anorexia nervosa. However, preclinical evidence that these drugs reduce activity and reward‐seeking behavior raises the possibility that they might attenuate the compulsive‐like hyperactivity central to ABA pathology and slow weight loss. Here, we employed a widely used rodent model of AN (activity‐based anorexia, ABA) to determine whether a GLP‐1R agonist would worsen or rather lessen weight loss and hyperactivity.
Method
Female mice that had continuous access to a running wheel and time‐restricted food availability received systemic administration of a GLP‐1R agonist, a GLP‐1R antagonist, or vehicle once daily before food presentation ( N = 10/group).
Results
GLP‐1R agonist treatment exacerbated ABA‐associated weight loss, confirming the concern that appetite suppression would worsen outcomes and failing to support the possibility that reduced compulsive‐like activity might provide benefit. This effect was driven by a further suppression of food intake, while wheel running remained unchanged. Pharmacological blockade of GLP‐1R signaling had no detectable effect on any parameter monitored relative to vehicle controls.
Discussion
These findings provide the first experimental evidence that GLP‐1R agonism worsens outcomes in an animal model of anorexia nervosa. The lack of effect of GLP‐1R antagonism suggests endogenous GLP‐1 signaling does not substantially contribute to ABA pathology. Together, these data raise caution regarding the use of GLP‐1R agonists in individuals vulnerable to restrictive eating as they are unlikely to reduce the motivation for excessive activity and can further reduce food intake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington, USA.
ORCID-Profile: Amit Thakar, Travis E Brown, Shane T Hentges
Zitieren
APA
Thakar, A., Brown, T. E., & Hentges, S. T. (2026). GLP ‐1 Receptor Agonism Exacerbates Activity‐Based Anorexia in Mice. International Journal of Eating Disorders, 59(11), 2549-2554. https://doi.org/10.1002/eat.70169
Vancouver
Thakar A, Brown TE, Hentges ST. GLP ‐1 Receptor Agonism Exacerbates Activity‐Based Anorexia in Mice. International Journal of Eating Disorders. 2026;59(11):2549-2554. doi:10.1002/eat.70169
BibTeX
@article{Thakar2026,
author = {Thakar, Amit and Brown, Travis E and Hentges, Shane T},
title = {GLP ‐1 Receptor Agonism Exacerbates Activity‐Based Anorexia in Mice},
journal = {International Journal of Eating Disorders},
year = {2026},
volume = {59},
number = {11},
pages = {2549--2554},
doi = {10.1002/eat.70169}
}
EUVIMED